Nuveen Asset Management »

Dianthus Therapeutics shares owned by Nuveen Asset Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Nuveen Asset Management from 13F filings

Historical chart of Nuveen Asset Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Nuveen Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.2M 87k 25.88

More positions owned by Nuveen Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
JPMorgan Chase & Co. (JPM)
Costco Wholesale Corporation (COST)
Nushares Etf Tr Get Opp Etf (NUGO)
Visa Com Cl A (V)

View all positions for Nuveen Asset Management

Top funds holding Dianthus Therapeutics

Bain Capital Life Sciences Investors
Avidity Partners Management
Fairmount Funds Management
RA Capital Management
Octagon Capital Advisors
VR Adviser
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Henderson Group
Braidwell
Geode Capital Management
Point72 Asset Management
State Street Corporation

View all funds holding Dianthus Therapeutics